Literature DB >> 9867486

The role of azithromycin in the treatment of Helicobacter pylori infection - a retrospective report.

W Dohmen1, R E Seelis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9867486     DOI： 10.1007/bf02962382

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  22 in total

1.  Failure of azythromycin to eradicate Campylobacter pylori from the stomach because of acquired resistance during treatment.

Authors:  Y Glupczynski; A Burette
Journal:  Am J Gastroenterol       Date:  1990-01       Impact factor: 10.864

2.  Azithromycin levels in plasma and gastric tissue, juice and mucus.

Authors:  J D Harrison; J A Jones; D L Morris
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-10       Impact factor: 3.267

Review 3.  Strategies for Helicobacter pylori eradication in 1995: a review of international and Belgian experience.

Authors:  M Deltenre; C Jonas; J Otero; A Cozzoli; P Denis; A Burette; E de Koster
Journal:  J Physiol Pharmacol       Date:  1996-03       Impact factor: 3.011

4.  [Combined therapy with azithromycin and omeprazole for the eradication of Helicobacter pylori].

Authors:  B Bokemeyer
Journal:  Dtsch Med Wochenschr       Date:  1995-09-29       Impact factor: 0.628

Review 5.  Review article: omeprazole and the cytochrome P450 system.

Authors:  K U Petersen
Journal:  Aliment Pharmacol Ther       Date:  1995-02       Impact factor: 8.171

6.  Evaluation of the efficacy and tolerability of four different therapeutic regimens for the Helicobacter pylori eradication.

Authors:  A Tursi; G Cammarota; M Montalto; A Papa; L Cuoco; G M Veneto; O Cannizzaro; G Fedeli; G Gasbarrini
Journal:  Panminerva Med       Date:  1996-09       Impact factor: 5.197

7.  Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin.

Authors:  G Cammarota; A Tursi; A Papa; M Montalto; G Veneto; L Cuoco; G Fedeli; G Gasbarrini
Journal:  Aliment Pharmacol Ther       Date:  1996-12       Impact factor: 8.171

8.  Efficacy, safety and tolerability of azithromycin versus roxithromycin in the treatment of acute lower respiratory tract infections.

Authors:  K Laurent
Journal:  J Antimicrob Chemother       Date:  1996-06       Impact factor: 5.790

9.  A new therapeutic strategy for the eradication of Helicobacter pylori infection.

Authors:  M Patiti; M Longaroni; P Stella; P Tacchi
Journal:  Minerva Gastroenterol Dietol       Date:  1996-12

10.  Multicentre comparative study of the efficacy and safety of azithromycin compared with amoxicillin/clavulanic acid in the treatment of paediatric patients with otitis media.

Authors:  N Principi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-08       Impact factor: 3.267
View more
  2 in total

1.  Azithromycin-containing versus standard triple therapy for Helicobacter pylori eradication: a meta-analysis.

Authors:  Jie Dong; Xiao-Feng Yu; Jian Zou
Journal:  World J Gastroenterol       Date:  2009-12-28       Impact factor: 5.742

2.  Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori.

Authors:  Seung Won Ra; Marc A Sze; Eun Chong Lee; Sheena Tam; Yeni Oh; Nick Fishbane; Gerard J Criner; Prescott G Woodruff; Stephen C Lazarus; Richard Albert; John E Connett; Meilan K Han; Fernando J Martinez; Shawn D Aaron; Robert M Reed; S F Paul Man; Don D Sin
Journal:  Respir Res       Date:  2017-05-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.